Short stature-craniofacial anomalies-genital hypoplasia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2994OMIM:177980Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Short stature-craniofacial anomalies-genital hypoplasia syndrome is an extremely rare genetic condition that affects multiple body systems. It is sometimes referred to by its Orphanet designation (ORPHA:2994). The syndrome is characterized by three main features: significantly shorter-than-expected height (short stature), unusual facial features (craniofacial anomalies), and underdevelopment of the genital organs (genital hypoplasia). Craniofacial features may include an unusually shaped skull, a broad or flat nasal bridge, widely spaced eyes, and other distinctive facial characteristics. Genital hypoplasia means that the reproductive organs are smaller or less developed than expected for the person's age. Additional features may include skeletal abnormalities and developmental delays in some cases. Because this condition is so rare, the medical understanding of it is limited. There is currently no cure, and treatment focuses on managing individual symptoms. A team of specialists typically works together to address the various aspects of the syndrome, including growth support, hormonal therapy when needed, and surgical correction of certain physical features. Early diagnosis and coordinated care can help improve quality of life for affected individuals.

Also known as:

Key symptoms:

Short stature or significantly reduced heightUnusual facial featuresUnderdeveloped genitalsBroad or flat nasal bridgeWidely spaced eyesAbnormal skull shapeSkeletal abnormalitiesLow-set or unusually shaped earsSmall jawDelayed pubertyPossible developmental delays

Clinical phenotype terms (28)— hover any for plain English
Abnormal retinal vascular morphologyHP:0008046High hypermetropiaHP:0008499Amniotic constriction ringHP:0009775
Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Short stature-craniofacial anomalies-genital hypoplasia syndrome.

View clinical trials →

No actively recruiting trials found for Short stature-craniofacial anomalies-genital hypoplasia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Short stature-craniofacial anomalies-genital hypoplasia syndrome community →

No specialists are currently listed for Short stature-craniofacial anomalies-genital hypoplasia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Short stature-craniofacial anomalies-genital hypoplasia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Short stature-craniofacial anomalies-genital hypoplasia syndromeForum →

No community posts yet. Be the first to share your experience with Short stature-craniofacial anomalies-genital hypoplasia syndrome.

Start the conversation →

Latest news about Short stature-craniofacial anomalies-genital hypoplasia syndrome

No recent news articles for Short stature-craniofacial anomalies-genital hypoplasia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific tests should be done to confirm the diagnosis?,Would growth hormone therapy be appropriate for my child?,When should we start monitoring for puberty and consider hormone treatment?,Are there any surgical procedures that might help with the craniofacial features?,Should we pursue genetic testing to look for a specific cause?,What developmental milestones should we watch for?,Are there other specialists we should be seeing regularly?

Common questions about Short stature-craniofacial anomalies-genital hypoplasia syndrome

What is Short stature-craniofacial anomalies-genital hypoplasia syndrome?

Short stature-craniofacial anomalies-genital hypoplasia syndrome is an extremely rare genetic condition that affects multiple body systems. It is sometimes referred to by its Orphanet designation (ORPHA:2994). The syndrome is characterized by three main features: significantly shorter-than-expected height (short stature), unusual facial features (craniofacial anomalies), and underdevelopment of the genital organs (genital hypoplasia). Craniofacial features may include an unusually shaped skull, a broad or flat nasal bridge, widely spaced eyes, and other distinctive facial characteristics. Geni

At what age does Short stature-craniofacial anomalies-genital hypoplasia syndrome typically begin?

Typical onset of Short stature-craniofacial anomalies-genital hypoplasia syndrome is neonatal. Age of onset can vary across affected individuals.